WHO Guideline development

Slides:



Advertisements
Similar presentations
Evidence-based Dental Practice Developing guidelines or clinical recommendations Slide #1 This lecture follows the previous online lecture on evidence.
Advertisements

ENTITIES FOR A UN SYSTEM EVALUATION FRAMEWORK 17th MEETING OF SENIOR FELLOWSHIP OFFICERS OF THE UNITED NATIONS SYSTEM AND HOST COUNTRY AGENCIES BY DAVIDE.
Building an EU consensus for minimum quality standards June 2011, Brussels | WHO: Normative guidance on and quality standards in drug demand reduction.
Participation Requirements for a Guideline Panel Member.
Tufts-New England Medical Center Evidence-based Practice Center Boston, MA Joseph Lau, MD, Director Ethan Balk, MD, MPH, Associate Director Thomas Trikalinos,
Embedded research and development – design for RU - for policy & practice change HOW TO GUIDE ON RESEARCH & DEVELOPMENT: THE EMBEDDED APPROACH.
Participation Requirements for a Guideline Panel Co-Chair.
Engaging Patients and Other Stakeholders in Clinical Research
Participation Requirements for a Patient Representative.
Participation Requirements for a Guideline Panel PGIN Representative.
Critically Evaluating the Evidence: Tools for Appraisal Elizabeth A. Crabtree, MPH, PhD (c) Director of Evidence-Based Practice, Quality Management Assistant.
Summarising findings about the likely impacts of options Judgements about the quality of evidence Preparing summary of findings tables Plain language summaries.
Grading of Recommendations Assessment, Development and Evaluation (GRADE) Methodology.
CADTH Therapeutic Reviews
From Evidence to EMS Practice: Building the National Model Eddy Lang, MD, CFPC (EM), CSPQ SMBD-Jewish General Hospital, McGill University Montreal, Canada.
Critical Appraisal of Clinical Practice Guidelines
Illustrating the GRADE Methodology: The Cather Associated-UTI Case Study TEACH Level II Workshop 5 NYAM August 9 th, 2013 Craig A Umscheid, MD, MSCE, FACP.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
Development of Clinical Practice Guidelines for the NHS Dr Jacqueline Dutchak, Director National Collaborating Centre for Acute Care 16 January 2004.
Performance Measurement and Analysis for Health Organizations
11 Programme Strategies for Postpartum Family Planning: A new resource for FP programmes Mary Lyn Gaffield, PhD November 2013 Scientist, Human Reproduction.
U.S. Department of Agriculture Center for Nutrition Policy and Promotion Slides provided by the USDA Center for Nutrition Policy and Promotion.
Brief summary of the GRADE framework Holger Schünemann, MD, PhD Chair and Professor, Department of Clinical Epidemiology & Biostatistics Professor of Medicine.
Plan GRADE backgroundGRADE background confidence in estimates (quality of evidence)confidence in estimates (quality of evidence) evidence profilesevidence.
Deciding how much confidence to place in a systematic review What do we mean by confidence in a systematic review and in an estimate of effect? How should.
BMH CLINICAL GUIDELINES IN EUROPE. OUTLINE Background to the project Objectives The AGREE Instrument: validation process and results Outcomes.
Basic Nursing: Foundations of Skills & Concepts Chapter 9
WHO GUIDANCE FOR THE DEVELOPMENT OF EVIDENCE-BASED VACCINE RELATED RECOMMENDATIONS August 2011.
Developing evidence-based guidelines at WHO. Evidence-based guidelines at WHO | January 17, |2 |
Outcome On completion of this unit the student should be able to describe and evaluate programs implemented by international and Australian government.
Guidelines Recommandations. Role Ideal mediator for bridging between research findings and actual clinical practice Ideal tool for professionals, managers,
GDG Meeting Wednesday November 9, :30 – 11:30 am.
Evidence Based Practice (EBP) Riphah College of Rehabilitation Sciences(RCRS) Riphah International University Islamabad.
GRADE Grading of Recommendations Assessment, Development and Evaluation British Association of Dermatologists April 2014.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
Clinical Practice Guidelines: Can we fix Babel? Eddy Lang Department Chair, Emergency Alberta Health Services Associate Professor University of Calgary.
Ghada Aboheimed, Msc. Review the principles of an evidence based approach to clinical practice. Appreciate the value of EBM Describe the 5 steps of evidence.
From evidence to Policy: Paediatric guideline development in Kenya Mercy Mulaku.
Approach to guideline development
Why this talk? you will be seeing a lot of GRADE
Developing a guideline
Presentation Developed for the Academy of Managed Care Pharmacy
GUIDELINES Evaluation of National Rural Networks
Purpose and Process of WHO guideline development
Evidence-based Medicine
Conflicts of interest Major role in development of GRADE
MUHC Innovation Model.
Lithuanian Standards for Evaluation of EU Structural Funds
Guidelines International Network
Overview of the GRADE approach – selected slides
The NICE Citizens Council and the role of social value judgements
Guideline Development
STROBE Statement revision
Assessing the Evidence:
Presentation Developed for the Academy of Managed Care Pharmacy
Evidence-Based Practice
Dr Peter Groves MD FRCP Consultant Cardiologist
Assessment of Quality in Statistics GLOBAL ASSESSMENTS, PEER REVIEWS AND SECTOR REVIEWS IN THE ENLARGEMENT AND ENP COUNTRIES Mirela Kadic, Project Manager.
Kate Medlicott Wastewater and Sanitation Team Leader, WHO Geneva
WHAT is evaluation and WHY is it important?
Concepts of Nursing NUR 212
Methods 2018 Clinical Practice Guidelines Chapter 2
Module 6 Part B: Internet Resources
Health Technology Assessment in India
Towards WHO Guidelines on Environmental Noise
EAST GRADE course 2019 Creating Recommendations
GUIDELINE COLLABORATION Clinical Practice Guidelines, Development and Implementation in Mexico: International Forum Sandra Zelman Lewis, PhD November.
Evidence-Based Public Health
Presentation Developed for the Academy of Managed Care Pharmacy
From the Evidence Analysis to the Creation of Evidence Based Guidelines 1.
Presentation transcript:

WHO Guideline development James Kiarie Coordinator, Human Reproduction team, Department of Reproductive Health and Research, WHO

Introduce WHO Guidelines Describe the Process Discuss how the evidence is handled Discuss how recommendations made Outline specific Guidelines for family planning

Introduction The World Health Organization’s (WHO) primary mandate is to provide assistance to its Member States in achieving the goal of the highest attainable standard of health for all, including sexual and reproductive health. Through Norms and guidelines Research Technical support

What is a WHO guideline ? “A WHO guideline is any document, whatever its title, that contains WHO recommendations about health interventions, whether they be clinical, public health or policy interventions.” ”A recommendation provides information about what policy-makers, health-care providers or patients should do. It implies a choice between different interventions that have an impact on health and that have ramifications for the use of resources.” Filename

Guideline development at WHO is a standard process Filename

Why a Standardized Process 2007 Systematic review on Use of Evidence in WHO Guidelines Summaries of findings rarely used Rely heavily on specialty experts No representatives of those who will have to live with the recommendations No methodological experts Filename

WHO Guidelines Focus on end-users’ needs Are based on highest-quality evidence Incorporate multiple processes to minimize bias All judgments and decision-making are transparent and explicit

The Guideline Development Process WHO has internal regulations and standards for developing guidelines: WHO Handbook for guideline development WHO Guidelines Review Committee (GRC) monitors the guideline development process and ensures that the relevant regulations and standards are applied proposal content development technical unit  GRC  technical unit GRC  final approval

The Guideline Development Process In summary, the process includes: identification of priority questions and critical outcomes; retrieval of the evidence; assessment and synthesis of the evidence; formulation of recommendations; planning for dissemination, implementation, impact evaluation and updating.

Guideline development Process CIRE Continuous Identification and Review of Evidence GSG Guideline Steering Group GDG Guideline Development Group

Scoping Set up WHO steering group List the priority topics Formulate draft PICO questions Review by guideline development group List the priority topics Search the literature for relevant data and existing systematic reviews Filename

GRADE: Grades of Recommendation Assessment, Development and Evaluation Aim: to develop a common, transparent and sensible system for grading the quality of evidence and the strength of recommendations (over 100 systems) International group of guideline developers, methodologists, and clinicians from around the world (>100 contributors) – since 2000 International group: ACCP, AHRQ, Australian NMRC, BMJ Clinical Evidence, CC, CDC, McMaster Uni., NICE, Oxford CEBM, SIGN, UpToDate, USPSTF, WHO

Determinants of Quality World Health Organization 19 November 2018 Determinants of Quality RCTs start high 3 Factors raise the quality of the evidence Large magnitude of effect can upgrade one level Dose response relation Residual confounding unlikely to be responsible for observed effect 5 factors lower the quality of evidence Limitations of the studies, in design and execution Inconsistency Indirectness Imprecision Reporting bias Determinants: study design RCTs start high observational studies start low 5 factors lower Observational studies start low 13 13 13

Quality of the evidence The extent to which one can be confident that an estimate of effect or association is correct. High, further research is very unlikely to change our confidence in the estimate of effect Moderate, further research is likely to have an important impact on our confidence in the estimate and may change the estimate Low, further research is very likely to have an important impact on our confidence in the estimate and is likely to change the estimate Very low, any estimate of effect is very uncertain

WHO guidelines… Must meet the highest quality standards for evidence-based guidelines Must be based on high-quality systematic reviews of all relevant evidence Use GRADE, which provides an explicit approach to: Assessing the quality of the evidence across studies and outcomes Translating evidence to recommendations Incorporate multiple processes to minimize bias and optimize usability Must incorporate transparency in all judgments and decision making Filename

Formulation of recommendations Strength of each recommendation will be determined by assessing each intervention based on: desirable and undesirable effects; quality of available evidence; values and preferences related to interventions in different settings; cost of options available to health-care workers in different settings; the perceived likelihood of the recommendation being modified as a result of further research.

The Four Cornerstones of WHO’s FP evidence-based guidance Promoting Family Planning The Four Cornerstones of WHO’s FP evidence-based guidance Medical Eligibility Criteria for Contraceptive Use Selected Practice Recommendations for Contraceptive Use Guidelines for policy-makers and programme managers 5th edition 2015 3rd edition in 2016 WHO’s evidence-based guidance has four key “cornerstones”: Name tall four here. Draw attention to the following: MEC and SPR are designed to be used mainly by programme managers and policy makers, national/local experts. Their basic use in the country will be to help/guide develop national guidelines for FP. They are not designed to be used by health-care providers directly. The DMT and the Handbook, on the other hand, are targeted directly towards health-care providers (i.e. user friendly, easy to read, illustrations etc.) Tools for health-care providers Decision-Making Tool for Family Planning Clients and Providers(to be updated) Handbook for Family Planning Providers 2018

Unique situation with Family Planning Recommendations based on Choice Provides recommendations (> 2000) on eligibility for 25 methods of contraception

Thank you For more information, Follow us on Twitter @HRPresearch Website who.int/reproductivehealth